EP Patent

EP1609481B1 — Injectable pharmaceutical compositions comprising sodium diclofenac, beta-cyclodextrin and a polysorbate

Assigned to Altergon SA · Expires 2007-09-19 · 19y expired

What this patent protects

Injectable pharmaceutical compositions are described comprising sodium diclofenac, a beta -cyclodextrin and a polysorbate, suitable for subcutaneous and intramuscular administration.

USPTO Abstract

Injectable pharmaceutical compositions are described comprising sodium diclofenac, a beta -cyclodextrin and a polysorbate, suitable for subcutaneous and intramuscular administration.

Drugs covered by this patent

Patent Metadata

Patent number
EP1609481B1
Jurisdiction
EP
Classification
—
Expires
2007-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Altergon SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.